ADCYAP1 and pituitary tumor: PACAP may be involved in the differential release of luteinizing hormone and follicle-stimulating hormone observed in various physiological and pathological conditions, including PCOS, and certain pituitary tumors where high-affinity PACAP-binding sites have been identified [35].